WORK Medical director Lin Qisheng files Form 3

WORK Medical Technology Group LTD submitted an initial insider ownership report for director Lin Qisheng on Form 3.

Accepted by SEC EDGAR 05/28/2026 - 11:32 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

WORK Medical Technology Group LTD submitted an initial insider ownership report for director Lin Qisheng on Form 3. The data provided shows no reportable transactions, no listed holdings, and no derivative positions for this reporting person at the time of the filing.

Key Terms

Form 3, reportingPersons, issuerTicker

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3):"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reportingPersons regulatory

""reportingPersons": [ { "name": "Lin Qisheng""

issuerTicker financial

""issuerTicker": "WOK""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the WORK Medical (WOK) Form 3 filing for Lin Qisheng show?

The Form 3 filing identifies Lin Qisheng as a director of WORK Medical Technology Group LTD. The data provided shows no reportable security holdings or derivative positions for this reporting person at the time of the filing.

Does the WORK Medical (WOK) Form 3 report any insider share purchases or sales?

No insider purchases or sales are reported in this Form 3 for WORK Medical. All transaction counts and share amounts in the summary are zero, indicating no buy, sell, or derivative transactions in this filing.

What insider role does Lin Qisheng have at WORK Medical (WOK)?

According to the Form 3 data, Lin Qisheng is a director of WORK Medical Technology Group LTD. The filing classifies this person as a director and not as an officer or ten percent owner based on the provided fields.

Are any derivative securities disclosed for Lin Qisheng in the WORK Medical Form 3?

No derivative securities are disclosed for Lin Qisheng in this Form 3. The derivative summary is empty and the exercise-related counts in the transaction summary are zero, indicating no options or similar instruments reported here.

Does the WORK Medical (WOK) Form 3 include any gifts or tax-withholding transactions?

The Form 3 summary shows no gifts or tax-withholding transactions for Lin Qisheng. Gift-related and tax-withholding counts and share figures are all zero in the transaction summary provided.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lin Qisheng

(Last) (First) (Middle)

ROOM 401, NO. 71, LANE 4719

GONGHEXIN ROAD, BAOSHAN DISTRICT

(Street)

SHANGHAI 200435

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
WORK Medical Technology Group LTD [ WOK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Qisheng Lin	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)